The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Pharmaceutical Composition With Synergistic Anticonvulsant Effect - EP2037965

The patent EP2037965 was granted to Schwarz Pharma on Aug 30, 2017. The application was originally filed on Jun 15, 2007 under application number EP07764676A. The patent is currently recorded with a legal status of "Revoked".

EP2037965

SCHWARZ PHARMA
Application Number
EP07764676A
Filing Date
Jun 15, 2007
Status
Revoked
Dec 20, 2019
Publication Date
Aug 30, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ACCORD HEALTHCAREMay 30, 2018TER MEER STEINMEISTER & PARTNER -

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP1541138
INTERNATIONAL-SEARCH-REPORTUS5378729
INTERNATIONAL-SEARCH-REPORTUS5773475
INTERNATIONAL-SEARCH-REPORTWO2006079547
OPPOSITIONUS2007042969

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents